KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Nu Skin Enterprises (NUS) over the last 17 years, with Q3 2025 value amounting to $130.3 million.

  • Nu Skin Enterprises' Cost of Revenue fell 2228.24% to $130.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $542.5 million, marking a year-over-year decrease of 1878.65%. This contributed to the annual value of $652.0 million for FY2024, which is 1216.73% down from last year.
  • Latest data reveals that Nu Skin Enterprises reported Cost of Revenue of $130.3 million as of Q3 2025, which was down 2228.24% from $128.2 million recorded in Q2 2025.
  • In the past 5 years, Nu Skin Enterprises' Cost of Revenue ranged from a high of $280.6 million in Q2 2021 and a low of $118.5 million during Q1 2025
  • Moreover, its 5-year median value for Cost of Revenue was $188.1 million (2023), whereas its average is $197.4 million.
  • In the last 5 years, Nu Skin Enterprises' Cost of Revenue surged by 3393.63% in 2021 and then tumbled by 2363.96% in 2022.
  • Nu Skin Enterprises' Cost of Revenue (Quarter) stood at $263.3 million in 2021, then fell by 23.64% to $201.0 million in 2022, then dropped by 9.8% to $181.3 million in 2023, then fell by 8.77% to $165.4 million in 2024, then decreased by 21.25% to $130.3 million in 2025.
  • Its Cost of Revenue stands at $130.3 million for Q3 2025, versus $128.2 million for Q2 2025 and $118.5 million for Q1 2025.